The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma
Author:
Affiliation:
1. Department of Surgical and Radiological SciencesSchool of Veterinary Medicine, University of California Davis California
2. Department of Molecular Physiology and Biological PhysicsUniversity of Virginia Charlottesville Virginia
Funder
National Institutes of Health
NIH Office of the Director
National Cancer Institute
Publisher
Wiley
Subject
General Veterinary
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/vco.12526
Reference44 articles.
1. The role of pharmacogenetics in the treatment of osteosarcoma
2. Current and future therapeutic approaches for osteosarcoma
3. Canine osteosarcoma: Understanding its variability to improve treatment
4. Future directions in the treatment of osteosarcoma
5. Translational biology of osteosarcoma
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CBFβ is induced by spring viremia of carp virus and promotes virus replication in zebrafish;Developmental & Comparative Immunology;2023-10
2. p53 Deficiency-Dependent Oncogenicity of Runx3;Cells;2023-04-10
3. Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks;Cell Cycle;2022-06-14
4. The use of alkaline phosphatase and runx2 to distinguish osteosarcoma from other common malignant primary bone tumors in dogs;Veterinary Pathology;2022-03-06
5. RUNX2 as a promising therapeutic target for malignant tumors;Cancer Management and Research;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3